HENRY SCHEIN, INC. Gain (Loss) Related to Litigation Settlement
HENRY SCHEIN, INC. (HSIC) reported Gain (Loss) Related to Litigation Settlement of $0 for the 12-month period ending 2019-12-28, per its 10-K filed 2020-02-20.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2020-02-20
- HENRY SCHEIN, INC. gain (loss) related to litigation settlement for the quarter ending 2019-12-28 was $0.00.
- HENRY SCHEIN, INC. gain (loss) related to litigation settlement for the quarter ending 2019-09-28 was $0.00, a 100.00% decline year-over-year.
- HENRY SCHEIN, INC. gain (loss) related to litigation settlement for the quarter ending 2018-12-29 was $0.00, a 100.00% decline year-over-year.
- HENRY SCHEIN, INC. gain (loss) related to litigation settlement for the quarter ending 2018-09-29 was $38.49M.
- HENRY SCHEIN, INC. gain (loss) related to litigation settlement for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- HENRY SCHEIN, INC. gain (loss) related to litigation settlement for fiscal 2018 was $38.49M, a 622.78% increase from fiscal 2017.
- HENRY SCHEIN, INC. gain (loss) related to litigation settlement for fiscal 2017 was $5.33M.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 3 month as first filed | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|---|
| 2019-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $0.00 derived: sum of 2 quarters · filed 2020-02-20 | $0.00 10-K · filed 2020-02-20 | ||
| 2019-09-28 | $0.00 10-Q · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | |||
| 2018-12-29 | $0.00 10-K · filed 2020-02-20 | $38.49M derived: sum of 2 quarters · filed 2020-02-20 | $38.49M derived: sum of 3 quarters · filed 2020-02-20 | $38.49M 10-K · filed 2020-02-20 | |
| 2018-09-29 | $38.49M 10-K · filed 2020-02-20 | -$38.49M 10-Q · filed 2018-11-06 | $38.49M derived: sum of 2 quarters · filed 2020-02-20 | -$38.49M 10-Q · filed 2019-11-05 | $49.14M derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-06-30 | $0.00 10-K · filed 2020-02-20 | $0.00 derived: sum of 2 quarters · filed 2020-02-20 | $10.65M derived: sum of 3 quarters · filed 2020-02-20 | $10.65M derived: sum of 4 quarters · filed 2020-02-20 | |
| 2018-03-31 | $0.00 10-K · filed 2020-02-20 | $10.65M derived: sum of 2 quarters · filed 2020-02-20 | $10.65M derived: sum of 3 quarters · filed 2020-02-20 | ||
| 2017-12-30 | $10.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $10.65M derived: sum of 2 quarters · filed 2020-02-20 | $5.33M 10-K · filed 2020-02-20 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-06 | -$5.33M 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ (ACH) | United States | $0.057B | -0.87 |